Yajie Tang
State Key Laboratory Of Cardiovascular Disease, Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Antithrombotic treatment for migraine in patients with patent foramen ovale: multicentre, randomised, active controlled, open label trial.
Journal: BMJ (Clinical research ed.)
Published: July 29, 2026
A village doctor-led mobile health intervention for cardiovascular risk reduction in rural China: cluster randomised controlled trial.
Journal: BMJ (Clinical research ed.)
Published: May 27, 2025
Additive Predictive Value of Left Ventricular End-Diastolic Volume Index to the Development of Persistent Atrial Fibrillation in Nonobstructive Hypertrophic Cardiomyopathy.
Journal: Cardiology
Published: October 19, 2024
Hybrid versus catheter ablation for Hypertrophic CardioMyopathy with Atrial Fibrillation (HCM-AF): study protocol for a randomised controlled trial.
Journal: BMJ open
Published: October 09, 2024
Predictive value of NT-pro BNP on outcomes of children with ventricular septal defect surgery.
Journal: Frontiers in cardiovascular medicine
Published: June 25, 2024
Influence of operator volume on early outcomes of septal myectomy for isolated hypertrophic obstructive cardiomyopathy.
Journal: Journal of thoracic disease
Published: March 15, 2021
The effect of endoscopic vein harvesting in coronary artery bypass surgery.
Journal: Journal of thoracic disease
Published: July 10, 2020
Thoracoscopic Transmitral Myectomy for an Anatomically Complex Case With Midventricular Obstruction.
Thoracoscopic Transmitral Myectomy for an Anatomically Complex Case With Midventricular Obstruction.
Journal: The Annals of thoracic surgery
Published: April 05, 2020
Two-Port Thoracoscopic Myectomy for Hypertrophic Cardiomyopathy With Three-Dimensional Printing.
Journal: The Annals of thoracic surgery
Published: January 22, 2020
Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Journal: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
Published: May 21, 2019
CaMKII-δ9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repair.
Journal: Nature cell biology
Published: February 17, 2019
Long-Term Outcomes of Tricuspid Valve Surgery in Patients With Congenitally Corrected Transposition of the Great Arteries.
Journal: Journal of the American Heart Association
Published: June 07, 2018
Last Updated: 09/26/2026